Tapewire

NYSE · USD

MMS

MAXIMUS, INC.

Export transactions ↓
Tapewire entity
4224
SEC CIK
0001032220
Parsed reports
809

Last 12 months

Inside the activity.

6 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202520
Dec 202501
Jan 202600
Feb 202640
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 29, 2024 Filed Mar 4, 2024 17:59 UTC
HALEY JOHN JDirector
GrantDividend Equivalent Rights · Derivative 58.851 $0.00 $0.00
Disclosure

SEC source: 0001032220-24-000030 · primary_doc.xml · derivative · entry 1

HALEY JOHN J · CIK 0001215018 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,470.611

Underlying: Common Stock · 58.851 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 17:43 UTC
GOLINVAUX THERESA DPrincipal Accounting Officer
GrantDividend Equivalent Rights · Derivative 31.272 $0.00 $0.00
Disclosure

SEC source: 0001032220-24-000029 · primary_doc.xml · derivative · entry 1

GOLINVAUX THERESA D · CIK 0001741289 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,751.96

Underlying: Common Stock · 31.272 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 17:36 UTC
Caswell BruceCEO & President
GrantDividend Equivalent Rights · Derivative 611.637 $0.00 $0.00
Disclosure

SEC source: 0001032220-24-000028 · primary_doc.xml · derivative · entry 1

Caswell Bruce · CIK 0001311296 · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,176.723

Underlying: Common Stock · 611.637 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 17:30 UTC GrantDividend Equivalent Rights · Derivative 10.509 $0.00 $0.00
Disclosure

SEC source: 0001032220-24-000027 · primary_doc.xml · derivative · entry 1

Altman Anne K. · CIK 0001637502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,941.114

Underlying: Common Stock · 10.509 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 17:19 UTC GrantDividend Equivalent Rights · Derivative 7.23 $0.00 $0.00
Disclosure

SEC source: 0001032220-24-000026 · primary_doc.xml · derivative · entry 1

RAJAN GAYATHRI · CIK 0001698399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,023.284

Underlying: Common Stock · 7.23 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 17:06 UTC
Baylinson Ilene R.General Mgr - Health & Human
GrantDividend Equivalent Rights · Derivative 115.704 $0.00 $0.00
Disclosure

SEC source: 0001032220-24-000025 · primary_doc.xml · derivative · entry 1

Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,381.53

Underlying: Common Stock · 115.704 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 16:28 UTC
Mutryn DavidChief Financial Officer
GrantDividend Equivalent Rights · Derivative 144.425 $0.00 $0.00
Disclosure

SEC source: 0001032220-24-000023 · primary_doc.xml · derivative · entry 1

Mutryn David · CIK 0001896008 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,419.473

Underlying: Common Stock · 144.425 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
February 29, 2024 Filed Mar 5, 2024 19:33 UTC Amendment PurchaseCommon Stock 56.33 $84.06 $4,734.82
Disclosure

SEC source: 0001032220-24-000038 · primary_doc.xml · nonDerivative · entry 1

RAJAN GAYATHRI · CIK 0001698399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,839.065

F1 · shares: Shares purchased via dividend reinvestment.

Read SEC document
February 29, 2024 Filed Sep 10, 2024 18:53 UTC PurchaseCommon Stock 7.18 $84.05 $603.48
Disclosure

SEC source: 0001032220-24-000089 · primary_doc.xml · nonDerivative · entry 1

Warren Michael J. · CIK 0001698331 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,040.69

F1 · shares: Shares purchased via dividend reinvestment.

Read SEC document
February 16, 2024 Filed Feb 20, 2024 19:40 UTC
Mutryn DavidChief Financial Officer
SaleCommon Stock 8,000 $83.95 $671,624.00
Disclosure

SEC source: 0001032220-24-000016 · primary_doc.xml · nonDerivative · entry 1

Mutryn David · CIK 0001896008 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,123.53

F1 · security: These sales were completed pursuant to a 10b5-1 trading plan adopted by the reporting person on November 17, 2023.

F2 · price: The weighted average sales price for prices ranging from $83.20 to $84.70. The reporting person will provide full information regarding the number of shares purchased or sold at each separate price upon request by the Commission staff, the issuer, or a security holder of the issuer.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 21:02 UTC
Weipert TeresaGM - US Federal Services
SaleCommon Stock 2,145 $85.19 $182,737.05
Disclosure

SEC source: 0001032220-23-000120 · primary_doc.xml · nonDerivative · entry 1

Weipert Teresa · CIK 0001856024 · GM - US Federal Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,348.31

F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F2 · price: Weighted average sales price for prices ranging from $85.16 to $85.29. The reporting person will provide full information regarding the number of shares purchased or sold at each separate price upon request by the Commission staff, the issuer, or a security holder of the issuer.

Read SEC document
December 12, 2023 Filed Dec 14, 2023 19:35 UTC
Baylinson Ilene R.General Mgr - Health & Human
SaleCommon Stock 10,043 $85.57 $859,359.42
Disclosure

SEC source: 0001032220-23-000118 · primary_doc.xml · nonDerivative · entry 1

Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,001.935

F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

Read SEC document
December 04, 2023 Filed Dec 14, 2023 20:34 UTC
Link Michelle F.Chief of Human Resources
SaleCommon Stock 1,765 $85.21 $150,395.65
Disclosure

SEC source: 0001032220-23-000119 · primary_doc.xml · nonDerivative · entry 1

Link Michelle F. · CIK 0001808982 · Chief of Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,981.26

F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 18:38 UTC GrantDividend Equivalent Rights · Derivative 701.889 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000105 · primary_doc.xml · derivative · entry 1

RUDDY RAYMOND B · CIK 0001054997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,036.738

Underlying: Common Stock · 701.889 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 5, 2023 00:55 UTC
Caswell BruceCEO & President
GrantDividend Equivalent Rights · Derivative 70.904 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000115 · primary_doc.xml · derivative · entry 2

Caswell Bruce · CIK 0001311296 · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,803.35

Underlying: Common Stock · 70.904 shares

Expires not disclosed

F2 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F2 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F2 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 5, 2023 00:55 UTC
Caswell BruceCEO & President
Tax withholdingCommon Stock 49 $83.49 $4,091.01
Disclosure

SEC source: 0001032220-23-000115 · primary_doc.xml · nonDerivative · entry 1

Caswell Bruce · CIK 0001311296 · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 245,784.052

F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit.

Read SEC document
November 30, 2023 Filed Dec 5, 2023 00:40 UTC
GOLINVAUX THERESA DPrincipal Accounting Officer
GrantDividend Equivalent Rights · Derivative 14.61 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000114 · primary_doc.xml · derivative · entry 1

GOLINVAUX THERESA D · CIK 0001741289 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,080.525

Underlying: Common Stock · 14.61 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 5, 2023 00:33 UTC
Link Michelle F.Chief of Human Resources
GrantDividend Equivalent Rights · Derivative 18.205 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000113 · primary_doc.xml · derivative · entry 2

Link Michelle F. · CIK 0001808982 · Chief of Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,084.663

Underlying: Common Stock · 18.205 shares

Expires not disclosed

F2 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F2 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F2 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 5, 2023 00:33 UTC
Link Michelle F.Chief of Human Resources
Tax withholdingCommon Stock 7 $83.49 $584.43
Disclosure

SEC source: 0001032220-23-000113 · primary_doc.xml · nonDerivative · entry 1

Link Michelle F. · CIK 0001808982 · Chief of Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,746.26

F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit.

Read SEC document
November 30, 2023 Filed Dec 5, 2023 00:13 UTC
Mutryn DavidChief Financial Officer
GrantDividend Equivalent Rights · Derivative 37.209 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000112 · primary_doc.xml · derivative · entry 1

Mutryn David · CIK 0001896008 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,392.554

Underlying: Common Stock · 37.209 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 5, 2023 00:03 UTC GrantDividend Equivalent Rights · Derivative 32.765 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000111 · primary_doc.xml · derivative · entry 1

Warren Michael J. · CIK 0001698331 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,151.137

Underlying: Common Stock · 32.765 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 23:58 UTC GrantDividend Equivalent Rights · Derivative 7.218 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000110 · primary_doc.xml · derivative · entry 1

RAJAN GAYATHRI · CIK 0001698399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,016.054

Underlying: Common Stock · 7.218 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 23:53 UTC
Madsen JanDirector
GrantDividend Equivalent Rights · Derivative 49.916 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000109 · primary_doc.xml · derivative · entry 1

Madsen Jan · CIK 0001629769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,941.684

Underlying: Common Stock · 49.916 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 23:50 UTC
HALEY JOHN JDirector
GrantDividend Equivalent Rights · Derivative 58.76 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000108 · primary_doc.xml · derivative · entry 1

HALEY JOHN J · CIK 0001215018 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,411.76

Underlying: Common Stock · 58.76 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 23:46 UTC GrantDividend Equivalent Rights · Derivative 10.5 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000107 · primary_doc.xml · derivative · entry 1

Altman Anne K. · CIK 0001637502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,930.605

Underlying: Common Stock · 10.5 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 23:40 UTC
Baylinson Ilene R.General Mgr - Health & Human
GrantDividend Equivalent Rights · Derivative 32.26 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000106 · primary_doc.xml · derivative · entry 2

Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,010.02

Underlying: Common Stock · 32.26 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 23:40 UTC
Baylinson Ilene R.General Mgr - Health & Human
SaleCommon Stock 12 $83.49 $1,001.88
Disclosure

SEC source: 0001032220-23-000106 · primary_doc.xml · nonDerivative · entry 1

Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,717.3

F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit.

Read SEC document
November 30, 2023 Filed Jan 12, 2024 20:36 UTC PurchaseCommon Stock 56.592 $83.37 $4,717.83
Disclosure

SEC source: 0001032220-24-000004 · primary_doc.xml · nonDerivative · entry 4

RAJAN GAYATHRI · CIK 0001698399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,782.735

F1 · shares: Shares purchased via dividend reinvestment

Read SEC document
November 21, 2023 Filed Nov 22, 2023 15:56 UTC GiftCommon Stock 2,984 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000104 · primary_doc.xml · nonDerivative · entry 1

MONTONI RICHARD A · CIK 0001254635 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · In Trust

Disclosed balance after: 70,000

F1 · security: Reflects the gift of common stock to a charitable donor advised fund.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 22:42 UTC
Martinez John ThomasGeneral Counsel
GrantRestricted Stock Units · Derivative 7,331 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000103 · primary_doc.xml · derivative · entry 1

Martinez John Thomas · CIK 0001993862 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,331

Underlying: Common Stock · 7,331 shares

Expires not disclosed

F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026

F2 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026

F3 · balance_after: Reporting person also holds restricted stock units with respect to an additional 3,811 shares of common stock with varying vesting schedules.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 22:31 UTC
Weipert TeresaGeneral Manager - US Federal S
GrantRestricted Stock Units · Derivative 7,942 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000102 · primary_doc.xml · derivative · entry 1

Weipert Teresa · CIK 0001856024 · General Manager - US Federal S

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,942

Underlying: Common Stock · 7,942 shares

Expires not disclosed

F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026

F2 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026

F3 · balance_after: Reporting person also holds restricted stock units with respect to an additional 5,350.472 shares of common stock with varying vesting schedules.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 22:07 UTC
Mutryn DavidChief Financial officer
GrantRestricted Stock Units · Derivative 9,164 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000100 · primary_doc.xml · derivative · entry 3

Mutryn David · CIK 0001896008 · Chief Financial officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,164

Underlying: Common Stock · 9,164 shares

Expires not disclosed

F3 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F4 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026

F4 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026

F5 · balance_after: Reporting person also holds restricted stock units with respect to an additional 10,355.345 shares of common stock with varying vesting schedules.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 21:55 UTC
Baylinson Ilene R.General Manager - Health & Hum
GrantRestricted Stock Units · Derivative 7,331 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000099 · primary_doc.xml · derivative · entry 3

Baylinson Ilene R. · CIK 0001791080 · General Manager - Health & Hum

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,331

Underlying: Common Stock · 7,331 shares

Expires not disclosed

F3 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F4 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026

F4 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026

F5 · balance_after: Reporting person also holds restricted stock units with respect to an additional 8,977.76 shares of common stock with varying vesting schedules.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 21:40 UTC
GOLINVAUX THERESA DPrincipal Accounting Officer
GrantRestricted Stock Units · Derivative 2,520 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000098 · primary_doc.xml · derivative · entry 3

GOLINVAUX THERESA D · CIK 0001741289 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,520

Underlying: Common Stock · 2,520 shares

Expires not disclosed

F3 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F4 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 4-year ratable vest that occurs on 09/30/2024, 09/30/2025, 09/30/2026, and 09/30/2027.

F4 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 4-year ratable vest that occurs on 09/30/2024, 09/30/2025, 09/30/2026, and 09/30/2027.

F5 · balance_after: Reporting person also holds restricted stock units with respect to an additional 4,065.915 shares of common stock with varying vesting schedules.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 21:18 UTC
Link Michelle F.Chief Human Resource Officer
GrantRestricted Stock Units · Derivative 4,888 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000097 · primary_doc.xml · derivative · entry 3

Link Michelle F. · CIK 0001808982 · Chief Human Resource Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,888

Underlying: Common Stock · 4,888 shares

Expires not disclosed

F3 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

F4 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026

F4 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026

F5 · balance_after: Reporting person also holds restricted stock units with respect to an additional 5,088.458 shares of common stock with varying vesting schedules.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 22:19 UTC
Caswell BruceCEO & President
Tax withholdingCommon Stock 11,888 $82.31 $978,501.28
Disclosure

SEC source: 0001032220-23-000101 · primary_doc.xml · nonDerivative · entry 2

Caswell Bruce · CIK 0001311296 · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 245,733.023

F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 22:19 UTC
Caswell BruceCEO & President
GrantCommon Stock 24,611.023 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000101 · primary_doc.xml · nonDerivative · entry 1

Caswell Bruce · CIK 0001311296 · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,621.023

F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 10,705 performance stock units which were previously reported on a Form 4 filed on November 22, 2021.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 22:07 UTC
Mutryn DavidChief Financial officer
Tax withholdingCommon Stock 98 $82.31 $8,066.38
Disclosure

SEC source: 0001032220-23-000100 · primary_doc.xml · nonDerivative · entry 2

Mutryn David · CIK 0001896008 · Chief Financial officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,123.53

F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 22:07 UTC
Mutryn DavidChief Financial officer
GrantCommon Stock 213.766 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000100 · primary_doc.xml · nonDerivative · entry 1

Mutryn David · CIK 0001896008 · Chief Financial officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,221.53

F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 92.892 performance stock units which were previously reported on a Form 3 filed on December 1, 2021.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 21:55 UTC
Baylinson Ilene R.General Manager - Health & Hum
Tax withholdingCommon Stock 2,681 $82.31 $220,673.11
Disclosure

SEC source: 0001032220-23-000099 · primary_doc.xml · nonDerivative · entry 2

Baylinson Ilene R. · CIK 0001791080 · General Manager - Health & Hum

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,707.752

F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 21:55 UTC
Baylinson Ilene R.General Manager - Health & Hum
GrantCommon Stock 5,349.325 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000099 · primary_doc.xml · nonDerivative · entry 1

Baylinson Ilene R. · CIK 0001791080 · General Manager - Health & Hum

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,388.752

F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 2,326.38 performance stock units which were previously reported on a Form 4 filed on November 22, 2021.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 21:40 UTC
GOLINVAUX THERESA DPrincipal Accounting Officer
Tax withholdingCommon Stock 181 $82.31 $14,898.11
Disclosure

SEC source: 0001032220-23-000098 · primary_doc.xml · nonDerivative · entry 2

GOLINVAUX THERESA D · CIK 0001741289 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,787.471

F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 21:40 UTC
GOLINVAUX THERESA DPrincipal Accounting Officer
GrantCommon Stock 400.04 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000098 · primary_doc.xml · nonDerivative · entry 1

GOLINVAUX THERESA D · CIK 0001741289 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,968.471

F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 173.67 performance stock units which were previously reported on a Form 3 filed on December 1, 2021.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 21:18 UTC
Link Michelle F.Chief Human Resource Officer
Tax withholdingCommon Stock 1,448 $82.31 $119,184.88
Disclosure

SEC source: 0001032220-23-000097 · primary_doc.xml · nonDerivative · entry 2

Link Michelle F. · CIK 0001808982 · Chief Human Resource Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,740.337

F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit.

Read SEC document
November 17, 2023 Filed Nov 21, 2023 21:18 UTC
Link Michelle F.Chief Human Resource Officer
GrantCommon Stock 3,208.577 $0.00 $0.00
Disclosure

SEC source: 0001032220-23-000097 · primary_doc.xml · nonDerivative · entry 1

Link Michelle F. · CIK 0001808982 · Chief Human Resource Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,188.337

F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 1,395.424 performance stock units which were previously reported on a Form 4 filed on November 22, 2021.

Read SEC document
September 29, 2023 Filed Oct 2, 2023 17:33 UTC
Weipert TeresaGeneral Mgr US Federal Segment
SaleCommon Stock 1,444 $74.68 $107,837.92
Disclosure

SEC source: 0001032220-23-000087 · primary_doc.xml · nonDerivative · entry 1

Weipert Teresa · CIK 0001856024 · General Mgr US Federal Segment

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,493.31

F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units

F2 · balance_after: In addition, the reporting person holds 5350.472 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock.

Read SEC document
September 29, 2023 Filed Oct 2, 2023 17:25 UTC
Mutryn DavidChief Financial Officer
SaleCommon Stock 3,886 $74.68 $290,206.48
Disclosure

SEC source: 0001032220-23-000086 · primary_doc.xml · nonDerivative · entry 1

Mutryn David · CIK 0001896008 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,007.76

F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units.

F2 · balance_after: In addition, the reporting person holds 10355.345 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock.

Read SEC document
September 29, 2023 Filed Oct 3, 2023 18:21 UTC
Baylinson Ilene R.General Mgr - Health & Human
SaleCommon Stock 7,073 $74.68 $528,211.64
Disclosure

SEC source: 0001032220-23-000089 · primary_doc.xml · nonDerivative · entry 1

Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,083

F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units.

F2 · balance_after: In addition, the reporting person holds 8977.76 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock.

Read SEC document
September 29, 2023 Filed Oct 3, 2023 17:14 UTC
Caswell BruceCEO & President
SaleCommon Stock 21,049 $74.68 $1,571,939.32
Disclosure

SEC source: 0001032220-23-000088 · primary_doc.xml · nonDerivative · entry 1

Caswell Bruce · CIK 0001311296 · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,010

F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units.

F2 · balance_after: In addition, the reporting person holds 19732.446 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock.

Read SEC document
September 28, 2023 Filed Oct 2, 2023 17:18 UTC
Link Michelle F.Chief of Human Resources
SaleCommon Stock 2,384 $74.68 $178,037.12
Disclosure

SEC source: 0001032220-23-000085 · primary_doc.xml · nonDerivative · entry 1

Link Michelle F. · CIK 0001808982 · Chief of Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,979.77

F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units.

F2 · balance_after: In addition, the reporting person holds 5066.458 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.